1. Home
  2. MPTI vs PMVP Comparison

MPTI vs PMVP Comparison

Compare MPTI & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$66.33

Market Cap

246.1M

Sector

N/A

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.29

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
PMVP
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.1M
79.5M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MPTI
PMVP
Price
$66.33
$1.29
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$71.00
N/A
AVG Volume (30 Days)
75.0K
364.4K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.62
N/A
Revenue
$54,417,000.00
N/A
Revenue This Year
$12.84
N/A
Revenue Next Year
$8.55
N/A
P/E Ratio
$25.51
N/A
Revenue Growth
11.03
N/A
52 Week Low
$36.38
$0.83
52 Week High
$79.58
$1.88

Technical Indicators

Market Signals
Indicator
MPTI
PMVP
Relative Strength Index (RSI) 50.31 41.97
Support Level $60.19 $1.26
Resistance Level $67.09 $1.50
Average True Range (ATR) 4.37 0.06
MACD 0.04 -0.03
Stochastic Oscillator 38.79 18.57

Price Performance

Historical Comparison
MPTI
PMVP

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: